Skip to content

Clinical trials

Recurrence trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Country / region: Netherlands Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20062
20072
20096
20105
20115
20127
20135
20146
20155
20169
20176
20189
20197
20208
20217
20225
202313
20245
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Recruiting20
Active, not recruiting17
Terminated17
Unknown status7
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene12
Novartis Pharmaceuticals12
AbbVie6
Biogen5
Maastricht University Medical Center5
Princess Maxima Center for Pediatric Oncology5
Amgen4
Janssen Research & Development, LLC4
Radboud University Medical Center4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence128
Multiple Myeloma23
Neoplasms18
Leukemia, Myeloid, Acute13
Neoplasm Metastasis11
Leukemia10
Lymphoma, Large B-Cell, Diffuse10
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Lymphoma, Non-Hodgkin7
Colorectal Neoplasms6

Trials

Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.